A diagnosis of prediabetes when combined with lifestyle advice and support is considered helpful rather than a negative label by a demographically diverse group: A qualitative study.

Healthy lifestyle Patient harm Prediabetes Qualitative research Screening Type 2 diabetes prevention

Journal

Primary care diabetes
ISSN: 1878-0210
Titre abrégé: Prim Care Diabetes
Pays: England
ID NLM: 101463825

Informations de publication

Date de publication:
04 2022
Historique:
received: 30 07 2021
revised: 16 09 2021
accepted: 02 10 2021
pubmed: 27 12 2021
medline: 18 5 2022
entrez: 26 12 2021
Statut: ppublish

Résumé

The aim of this study was to explore the experience and perceptions of a diagnosis of prediabetes among a demographically diverse sample of New Zealanders who had, and had not, regressed to normoglycaemia following participation in a primary care nurse-delivered intervention for 6 months. The sample included Indigenous Māori who have high rates of diabetes and associated co-morbidities. A purposefully selected sample of 58 people with prediabetes and BMI >25 kg/m Most participants recalled being shocked when told they had prediabetes, but they did not perceive the diagnosis to be a label in a negative sense, and some, described the diagnosis as helpful. Participants appreciated knowing that prediabetes could be reversed, and the opportunity to be able to take supported action and make lifestyle changes through the nurse-delivered prediabetes lifestyle intervention. Participants' clear preference was to take control and make dietary changes, not to take Metformin. Prediabetes was not considered a negative label, but an opportunity, when coupled with a primary care nurse-delivered dietary intervention.

Identifiants

pubmed: 34953750
pii: S1751-9918(21)00188-1
doi: 10.1016/j.pcd.2021.10.003
pii:
doi:

Substances chimiques

Metformin 9100L32L2N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-306

Informations de copyright

Copyright © 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Auteurs

Kirsten J Coppell (KJ)

Department of Medicine, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin 9054, New Zealand. Electronic address: kirsten.coppell@otago.ac.nz.

Sally Abel (S)

Kaupapa Consulting Ltd., 52 Vigor Brown St, Napier 4110, New Zealand.

Lisa C Whitehead (LC)

School of Nursing and Midwifery, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA 6027, Australia.

Angeline Tangiora (A)

Health Hawke's Bay, 100 McLeod Street, Hastings 4120, New Zealand.

Terrie Spedding (T)

Health Hawke's Bay, 100 McLeod Street, Hastings 4120, New Zealand.

David Tipene-Leach (D)

Eastern Institute of Technology, 501 Gloucester Street, Taradale, Napier 4112, Hawke's Bay, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH